Hughes, D., Boyd, S., Giraldo, P., Gonzalez, D., Holida, M., Goker-Alpan, O., … Chertkoff, R. (2016). Novel treatment for Fabry disease: IV administration of plant derived alpha-gal-A enzyme safety and efficacy interim report. In Molecular Genetics and Metabolism (Vol. 117, pp. S59–S59). Elsevier BV. https://doi.org/10.1016/j.ymgme.2015.12.296

Hughes, Derralynn, Simeon Boyd, Pilar Giraldo, Derlis Gonzalez, Myrl Holida, Ozlem Goker-Alpan, Gustavo Megawa, et al. “Novel treatment for Fabry disease: IV administration of plant derived alpha-gal-A enzyme safety and efficacy interim report.” In Molecular Genetics and Metabolism, 117:S59–S59. Elsevier BV, 2016. https://doi.org/10.1016/j.ymgme.2015.12.296.

Hughes D, Boyd S, Giraldo P, Gonzalez D, Holida M, Goker-Alpan O, et al. Novel treatment for Fabry disease: IV administration of plant derived alpha-gal-A enzyme safety and efficacy interim report. In: Molecular Genetics and Metabolism. Elsevier BV; 2016. p. S59–S59.

Hughes, Derralynn, et al. “Novel treatment for Fabry disease: IV administration of plant derived alpha-gal-A enzyme safety and efficacy interim report.” Molecular Genetics and Metabolism, vol. 117, no. 2, Elsevier BV, 2016, pp. S59–S59. Crossref, doi:10.1016/j.ymgme.2015.12.296.

Hughes D, Boyd S, Giraldo P, Gonzalez D, Holida M, Goker-Alpan O, Megawa G, Atta M, Nicholls K, Schiffmann R, Tuffaha A, Visootsak J, Barisoni L, Colvin R, Charles Jannette J, Alon S, Krupko J, Szlaifer M, Brill-Almon E, Chertkoff R. Novel treatment for Fabry disease: IV administration of plant derived alpha-gal-A enzyme safety and efficacy interim report. Molecular Genetics and Metabolism. Elsevier BV; 2016. p. S59–S59.